Medicine recalls
|
| |
| Singapore: Recall of Apo-Fluticasone Aqueous Nasal Spray 50mcg/Spray |
| |
Health Sciences Authority (HSA) announces that Pharmaforte Singapore Pte Ltd is recalling one batch of Apo-Fluticasone Aqueous Nasal Spray 50mcg/Spray (fluticasone propionate) (batch number: TW4749) to the retail level because the product was supplied with shelf-life discrepancy (non-approved shelf-life).
Fluticasone propionate nasal spray is used for symptomatic treatment of seasonal or perennial allergic rhinitis and also for perennial nonallergic rhinitis.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/product-recall/recall-of-apo-fluticasone-aqueous-nasal-spray-50mcg-spray
In Hong Kong, Apo-Fluticasone Aqueous Nasal Spray 50mcg/dose (HK-60810) is a pharmaceutical product registered by Hind Wing Co Ltd (Hind Wing). The product is a prescription-only medicine. The Department of Health has contacted Hind Wing and the company confirmed that the concerned batch has been supplied to Hong Kong in accordance with the approved shelf-life and without any shelf-life discrepancy. The above HSA announcement has no impact on the local market in Hong Kong.
Ends/Friday, Dec 12, 2025
Issued at HKT 18:00
|
| |
